금융 뉴스 허브

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $458.99, denoting a +1.28% move from the preceding trading day.

Stock-market pessimists have one less reason to worry as shares of banks and retailers perk up

The rally is once again broadening beyond tech

Update: US Equity Indexes Drop as Bets for Higher Interest Rates Jump After Fed Eliminates Easing Bias

(Updates with index/price moves, FedWatch outlook, macro data, and political/company news from the f

Smart Digital Group faces Nasdaq delisting on June 24

Dow Retreats From Highs in Broad Sell-Off Following Fed Decision

The Dow Jones Industrial Average fell from record highs Wednesday as markets reacted to the Federal

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 11, 2026, the company approved non-statutory stock options to purchase an aggregate of 10,050 shares of its common stock and 11,870 r ...

Smith & Wesson Brands Non-GAAP EPS of $0.36 beats by $0.13, revenue of $178.4M beats by $23.13M

Safe Bulkers Non-GAAP EPS of $0.18 beats by $0.09, revenue of $74.4M beats by $8.9M

Update: US Equity Indexes Drop, Treasury Yields Surge After Fed Removes Easing Bias

(Updates with index/price moves and macroeconomic news from the first paragraph.) US equity index

Hawkish Warsh sparks selloff as traders bet on higher rates ahead

Anheuser-Busch InBev appoints new chairman as its strong turnaround continues

Dow Reaches Historic Peak With Fed Decision Hours Away

Dow Hits Milestone High as Investors Watch Fed and Iran Developments